Medco Following Through On Companion Dx To Limit Drug Use
This article was originally published in The Gray Sheet
The pharmacy benefit manager has prior authorization requirements for two expensive targeted oncology drugs, Xalkori and Zelboraf.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.